Physician profile
Marlene Hamama
NPI 1770904971
$1,125.83
in general payments reported to CMS, 2019-2025
16 companies · $120 in 2025
The $120 reported for 2025 was less than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $169 · 2022: $179 · 2023: $409 · 2024: $249 · 2025: $120.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $778.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $777.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $409.05 | 2022-2025 | |
| Collegium Pharmaceutical, INC. | $194.37 | 2021-2025 | Belbuca, Xtampza |
| Medtronic, INC. | $109.13 | 2021-2023 | Intellis Adaptivestim, Synchromedii |
| Saluda Medical Americas, INC. | $84.92 | 2023 | Evoke Scs |
| Boston Scientific Corporation | $62.08 | 2021 | |
| Amgen INC. | $57.13 | 2022 | |
| Redhill Biopharma INC. | $47.91 | 2022-2023 | Aemcolo, Talicia, Movantik |
| Spr Therapeutics, INC | $27.95 | 2022-2023 | Sprint Pns System |
| Scilex Pharmaceuticals INC. | $22.52 | 2021 | |
| Spinal Simplicity, LLC | $20.36 | 2025 | Ha Minuteman G3-R |
| Vertex Pharmaceuticals Incorporated | $20.22 | 2025 | |
| Biotissue Holdings INC. | $17.51 | 2024 | |
| Biodelivery Sciences International, INC. | $14.02 | 2021 | |
| Depuy Synthes Sales INC. | $13.39 | 2024 | Orthovisc, Monovisc |
| Grt US Holding, INC. | $12.79 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $12.48 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marlene Hamama listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.